Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Snynf save search
Global Plant Based API Market Analysis Report 2023-2028: Many Pharmaceutical Companies are Now Developing Plant-based APIs to Meet Demand
Published: 2023-08-28 (Crawled : 15:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.06%
H: 0.06%
C: -0.51%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: 0.0%
companies report global market
Global Peanut Allergy Treatment Research Report 2023-2028: Pioneering Treatments Across Antihistamines, Epinephrine, & Immunotherapies Emerge Amid Rising Peanut Allergy Cases
Published: 2023-08-25 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
|
| O: 10.4%
H: 0.0%
C: 0.0%
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 0.52%
H: 0.31%
C: -0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: 0.0%
report peanut treatment research global
FDA Decisions 2023: Sandoz, Gilead Sciences and More
Published: 2023-08-25 (Crawled : 15:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: 0.03%
H: 0.61%
C: -0.03%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: 0.0%
fda sciences
Analysis of the Global AI in Clinical Trials Industry, 2023 to 2035 - Product/Technology Utilization and Integration Agreements Lead the Way in Partnerships
Published: 2023-08-25 (Crawled : 14:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: 0.0%
integration trials global
Peripheral Artery Disease Global Market to Surpass USD 54 Billion Mark by 2027 | DelveInsight
Published: 2023-08-24 (Crawled : 21:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
|
| O: -1.79%
H: 3.86%
C: -0.01%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
TRUMY | $16.507 0.79% 34K
|
Manufacturing
|
| O: 3.84%
H: 1.02%
C: -2.01%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 0.96%
H: 0.25%
C: -0.32%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.28%
H: 0.48%
C: 0.38%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: 0.0%
disease global market
Aily Labs Raises €19M in Series A Round Led by Insight Partners
Published: 2023-08-24 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: 0.0%
Everest Group Report: Growing Importance of Revenue Management Outsourcing
Published: 2023-08-24 (Crawled : 15:00) - modeln.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.72%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.82%
H: 0.49%
C: -0.32%
management group growing
Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to its Board of Directors and Names Dr. Richard Peters as Chairman
Published: 2023-08-24 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.72%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.82%
H: 0.49%
C: -0.32%
APRE | $5.65 0.71% 0.71% 7.2K
|
Health Technology
|
| O: -4.93%
H: 5.18%
C: 5.18%
therapeutics
Bob Dagher: Promoting Teamwork to Bring BrainStorm Across the Finish Line
Published: 2023-08-24 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.72%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.82%
H: 0.49%
C: -0.32%
FDA Decisions 2023: Pfizer, Neurocrine and Regeneron
Published: 2023-08-23 (Crawled : 15:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: 0.16%
H: 0.22%
C: 0.13%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
fda
Innovent Announces 2023 Interim Results and Business Updates
Published: 2023-08-23 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.39%
H: 0.37%
C: -0.6%
business results
GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
Published: 2023-08-23 (Crawled : 12:00) - globenewswire.com
GHRS | $11.055 -1.21% -1.22% 63K
|
Manufacturing
|
| O: -0.47%
H: 2.72%
C: -1.41%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
business research financial results
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
Published: 2023-08-22 (Crawled : 23:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
cancer thyroid retevmo trial
Regeneron Announces Agreement with BARDA Supporting Development of Next-Generation Antibody Therapy for COVID-19 Prevention
Published: 2023-08-22 (Crawled : 18:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.52%
H: 0.3%
C: -0.5%
covid-19 antibody agreement therapy
Pfizer Wins FDA Approval for First Maternal RSV Shot to Protect Infants
Published: 2023-08-22 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
fda approval rsv
Genprex Appoints Suzanne Thornton-Jones as Senior Vice President, Regulatory Affairs
Published: 2023-08-22 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: -2.58%
H: 14.23%
C: 10.72%
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight
Published: 2023-08-21 (Crawled : 21:00) - prnewswire.com
COYA | $7.87 -6.75% -7.24% 54K
|
|
| O: 2.92%
H: 4.26%
C: -0.28%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.3%
H: 1.19%
C: 0.75%
URGN | $13.78 -3.37% -3.48% 390K
|
Health Technology
|
| O: 0.0%
H: 2.26%
C: -0.34%
SEEL | $0.3502 3.61% 3.48% 290K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -9.02%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
PRTA 4 | $21.17 2.92% 2.83% 510K
|
Health Technology
|
| O: 0.03%
H: 1.36%
C: -0.07%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -0.15%
H: 1.02%
C: 0.46%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.08%
H: 1.11%
C: -0.06%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -0.6%
H: 1.75%
C: 0.3%
BIVI | $0.4874 -0.21% -0.21% 490K
|
Health Technology
|
| O: -0.85%
H: 3.43%
C: 1.71%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.38%
H: 0.67%
C: -0.41%
global medical growth market
Global Diabetes Drugs Market to Reach $106.65 Billion by 2028: Rising Prevalence of Diabetes Fuels Growth
Published: 2023-08-21 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.16%
H: 0.51%
C: 0.51%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.5%
H: 0.52%
C: 0.43%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -2.16%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.76%
H: 0.23%
C: -0.14%
reach global diabetes growth market
Former CEO and Chairman of the Board of Bayer Pharma AG, Dieter Weinand, Joins Coya’s Board of Directors
Published: 2023-08-21 (Crawled : 12:00) - biospace.com/
COYA | $7.87 -6.75% -7.24% 54K
|
|
| O: -0.87%
H: 5.44%
C: 0.59%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
REPL | $6.47 -7.17% -7.73% 870K
|
Health Technology
|
| O: -0.21%
H: 3.04%
C: 1.55%
pharma ceo
EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for Treatment of Wet Age-related Macular Degeneration (wAMD), Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR)
Published: 2023-08-18 (Crawled : 23:00) - globenewswire.com
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
fda eylea macular approved treatment injection diabetic
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.